WO1997044304A1 - Process for the catalytic hydrogenation of terpenoids - Google Patents
Process for the catalytic hydrogenation of terpenoids Download PDFInfo
- Publication number
- WO1997044304A1 WO1997044304A1 PCT/EP1997/002525 EP9702525W WO9744304A1 WO 1997044304 A1 WO1997044304 A1 WO 1997044304A1 EP 9702525 W EP9702525 W EP 9702525W WO 9744304 A1 WO9744304 A1 WO 9744304A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogenation
- catalyst
- transition metal
- group
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/02—Additives for beer
- C12C5/026—Beer flavouring preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
- C07B35/02—Reduction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
- C07C5/02—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
- C07C5/03—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation of non-aromatic carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C3/00—Treatment of hops
- C12C3/12—Isomerised products from hops
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C9/00—Methods specially adapted for the making of beerwort
- C12C9/02—Beerwort treatment; Boiling with hops; Hop extraction
- C12C9/025—Preparation of hop extracts ; Isomerisation of these extracts; Treatment of beerwort with these extracts; Surrogates of the hop
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- C07C2531/06—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing polymers
Definitions
- the present invention relates to a process for the catalytic hydrogenation of terpenoids in the presence of a transition metal catalyst in a homogeneous phase.
- terpenoid compounds Due to their natural occurrence and the associated physiological harmlessness, terpenoid compounds play an increasingly important role, for example in the food, luxury food or cosmetics industries.
- hop ingredients such as humulones, isohumulones or lupulones, which are known to be used as condiments in brewing beer.
- a disadvantage here is the low lightfastness of these hop ingredients, so that special precautions are required when storing the beer so that there is no undesirable change in the smell or taste.
- terpenoids Another example of the chemical modification of terpenoids is the hydrogenation of squalene (2,6,10,15, 19,23-hexamethyl-2,6,10,14,18,22-tetrakosahexaene) to squalane, which on a large scale is used as an ointment base in pharmaceutical or cosmetic preparations.
- the hydrogenation processes known for the production of squalane also have the serious disadvantage that they are technically very complex and cause comparatively high operating and investment costs.
- the present invention was therefore based on the object of developing a process for the catalytic hydrogenation of terpenoids with hydrogen in the presence of a transition metal catalyst which does not have the disadvantages of the prior art mentioned, but also extensive hydrogenation of the corresponding starting compounds with little technical outlay enables.
- transition metals of the eighth subgroup of the periodic table consist of a reaction product of transition metals of the eighth subgroup of the periodic table and special polymer compounds.
- the metals are Palladium, platinum, nickel, rhodium and ruthenium and mixtures of these metals are to be regarded as particularly preferred. Mixtures of palladium and platinum, for example, have proven particularly useful.
- the polymer component of the catalyst used according to the invention consists of polyvinylpyrrolidone (PVP), polyethyleneimine (PEI) derivatives or starch derivatives.
- PVP polyvinylpyrrolidone
- PEI polyethyleneimine
- starch derivatives polyvinylpyrrolidones with a relatively low molecular weight of approximately 10,000 to 50,000 are preferably used here.
- Polyethyleneimine derivatives include both polyethyleneimines with a preferred molecular weight of 1,000 to 50,000 or derivatized compounds
- the derivatization can be carried out with the appropriate alkylating agents (such as methyl iodide or dimethyl sulfate), acylating agents (such as acetic anhydride) or epoxidation reagents (such as ethylene oxide, propylene oxide etc.).
- alkylating agents such as methyl iodide or dimethyl sulfate
- acylating agents such as acetic anhydride
- epoxidation reagents such as ethylene oxide, propylene oxide etc.
- the degree of derivatization of the polyethyleneimines is relatively unproblematic, i. H.
- the primary and secondary amino groups of the polyethyleneimine can, if desired, be derivatized in whole or in part.
- starch derivatives for the polymer compounds used according to the invention.
- a carboxymethylated starch with a degree of substitution of 0.5 to 3.0 is used as the starch derivative.
- the ratio of transition metal to polymer compound can be varied within wide limits within the scope of the present invention, but it has proven to be particularly advantageous to set the quantitative ratio of transition metal to polymer compound to 1:20 to 1:50.
- the catalytic hydrogenation reaction takes place in a homogeneous phase, because only in this way can rapid hydrogenation also take place under mild conditions.
- the hydrogenation reaction will preferably carried out in water or in alkaline aqueous solution, provided that the corresponding Te ⁇ enoide dissolve in these media.
- alkaline solution it is preferred to work in alkaline solution at a pH of 7.0 to 10.0.
- alcohols with 1 to 4 carbon atoms can also be used as solvents, where in the case of
- reaction temperature in the process according to the invention can also be varied within certain limits and depends essentially on the
- the reaction pressure is also relatively uncritical, i.e. it can be carried out either at normal pressure or to accelerate the reaction rate at an overpressure which, depending on the autoclaves available, can be up to 50 bar.
- the preparation of the catalysts used according to the invention is technically relatively easy to carry out and is described, for example, in US Pat. No. 4,419,490.
- a salt of the transition metal used is placed in a suitable solvent, then the polymer compound is optionally also added in dissolved form and finally the catalyst with a reducing agent such as e.g. Sodium borohydride (NaBH4) or hydrogen, reduced.
- a reducing agent such as e.g. Sodium borohydride (NaBH4) or hydrogen, reduced.
- the corresponding terpenoid can be added to the catalyst solution without prior isolation of the catalyst and the hydrogenation can be carried out under the respective reaction conditions, the hydrogen being preferably used in excess.
- Te ⁇ enoide within the scope of the present invention, hop ingredients such as.
- humulon, isohumulon or lupulon, or squalene can be used.
- the catalyst is separated off by customary methods, for example by ultrafiltration, and can easily be used again for hydrogenation reactions.
- the separated filtrate with the dissolved product can, if necessary, be isolated by removing the solvent or can be analyzed, for example, by HPLC or GC.
- the teipenoids used according to the invention are practically quantitatively hydrogenated, and neither the corresponding starting compounds nor any partially hydrogenated intermediates can be found.
- 0.3 ml of a methanolic Li2PdCl4 solution (palladium content: 3 mg) is diluted with 20 ml of ethanol, mixed with 5 ml of a 2% by weight aqueous PVP solution (K value: 25) and then with 5 mg sodium borohydride reduced at room temperature (duration: 15 minutes). Then 400 mg of isohumulone dissolved in 10 ml of ethanol are added to the catalyst solution and hydrogenated at room temperature and 1 bar within 3 hours (hydrogen absorption: 45 ml). The catalyst is then largely separated by ultrafiltration and the filtrate is analyzed by HPLC. The evaluation of the corresponding chromatogram shows that an almost quantitative hydrogenation of the exocyclic double bonds has occurred since neither the starting compound nor the dihydro compound was found.
- 0.3 ml of a methanolic L ⁇ 2PdCl4 solution (palladium content: 3 mg) is diluted with 20 ml of ethanol, with 5 ml of a 2% by weight aqueous solution of acetylated PEI (degree of acetylation approx. 25%; MW approx. 50 000) and then reduced with excess hydrogen at room temperature (duration: 30 minutes). 400 mg of isohumulone in 10 ml of ethanol are then added to the catalyst solution and the mixture is hydrogenated at room temperature and 1 bar for 3.5 hours (hydrogen absorption: 45 ml). The subsequent analysis by HPLC shows an almost quantitative hydrogenation of the exocyclic double bonds.
- aqueous Na2PdC.4 solution palladium content: 3 mg
- aqueous PVP solution K value: 25
- excess hydrogen at room temperature (duration: 30 minutes).
- 4 ml of a 10.5% strength aqueous isohumulone solution are added to the catalyst solution and hydrogenated at room temperature and 1 bar for about 10 hours (hydrogen absorption: 45 ml).
- the subsequent analysis by HPLC shows an almost quantitative hydrogenation of the exocyclic double bonds.
- aqueous Na2PdCl4 solution (palladium content: 10 mg) is diluted in 30 ml of water with 20 ml of a 2% by weight aqueous solution of acetylated PEI (degree of acetylation approx. 25%; MW approx. 50,000 ) and then reduced with excess hydrogen at room temperature (duration: 30 minutes). After the reduction has taken place, 40 ml of a 10% strength by weight aqueous isohumulone solution are added to the catalyst solution and hydrogenated at a temperature of 50 ° C. and normal pressure for about 8 hours (hydrogen absorption: 450 ml).
- the catalyst is separated from the hydrogenated isohumulone by means of ultrafiltration using a UV membrane with an exclusion limit of approximately 10,000 daltons. After redissolving, the catalyst can be used again for the hydrogenation. Analysis by HPLC shows a practically quantitative hydrogenation of the exocyclic double bonds.
- a methanolic Li2PdCl4 solution (palladium content: 3 mg) is diluted with 20 ml of ethanol, mixed with 5 ml of a 2% by weight ethanolic PVP solution (K value: 25) and the solution with Reduced hydrogen.
- K value 2% by weight ethanolic PVP solution
- 300 mg of humulon, dissolved in 10 ml of ethanol are added and the mixture is hydrogenated at room temperature and 1 bar of hydrogen pressure for 1 hour (hydrogen uptake: 30 ml).
- the soluble polymeric hydrogenation catalyst is separated by means of ultrafiltration (membrane with exclusion limit of 10,000 daltons), and the filtrate is analyzed by means of HPLC. The spectrum shows that the humulon used was almost completely hydrogenated to tetrahydrohumulon.
- 0.3 ml of a methanolic Li2PdCl4 solution (palladium content: 3 mg) is diluted with 20 ml of n-butanol, mixed with 2 ml of a 2% by weight aqueous solution of alkylated PEI (degree of alkylation approx. 50%) and then reduced with 5 mg sodium borohydride at room temperature (duration: 15 minutes). Then 2 g of squalene are added and the hydrogenation is carried out at 50 ° C. and 1 bar for a period of 3 hours (hydrogen uptake: 600 ml). The catalyst is then separated off by ultrafiltration and the filtrate is spun in. The yield is 1.92 g of squalane (yield: 93.7%) with a gas chromatographic purity of over 99%.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97923923A EP0901455A1 (en) | 1996-05-20 | 1997-05-16 | Process for the catalytic hydrogenation of terpenoids |
AU29567/97A AU2956797A (en) | 1996-05-20 | 1997-05-16 | Process for the catalytic hydrogenation of terpenoids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19620171.3 | 1996-05-20 | ||
DE1996120171 DE19620171A1 (en) | 1996-05-20 | 1996-05-20 | Process for the catalytic hydrogenation of terpenoids |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997044304A1 true WO1997044304A1 (en) | 1997-11-27 |
Family
ID=7794742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1997/002525 WO1997044304A1 (en) | 1996-05-20 | 1997-05-16 | Process for the catalytic hydrogenation of terpenoids |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0901455A1 (en) |
AU (1) | AU2956797A (en) |
DE (1) | DE19620171A1 (en) |
WO (1) | WO1997044304A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034762A1 (en) * | 1999-11-11 | 2001-05-17 | Miller Brewing Company | Method of hydrogenating iso-alpha acids in a buffered solution |
US8766013B2 (en) | 2010-06-14 | 2014-07-01 | Katholieke Universiteit Leuven | Method for hydrogenation of iso-alpha-acids and tetrahydro-iso-alpha-acids to hexahydro-iso-alpha-acids |
CN106519086A (en) * | 2016-11-03 | 2017-03-22 | 哈尔滨工业大学 | Polyvinyl pyrrolidine imine high-molecular compound, and preparation method and applications thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1236512A1 (en) * | 2001-02-28 | 2002-09-04 | Council Of Scientific And Industrial Research | Nanosized noble metal catalyst and process for selective preparation of 1,4 butenediol |
CN102686548A (en) * | 2009-11-13 | 2012-09-19 | 卡拉马祖控股股份有限公司 | Process for the preparation of tetrahydroisohumulone compositions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419490A (en) * | 1978-08-17 | 1983-12-06 | Heyl & Co. Chemisch-Pharmazeutische Fabrik | Polymeric hydrogenation catalysts, the production thereof and their use to promote hydrogenation |
GB2217729A (en) * | 1987-03-25 | 1989-11-01 | Tadeval S A | Preparation of Squalane |
US5013571A (en) * | 1990-01-31 | 1991-05-07 | Pfizer Inc. | Methods for making tetrahydroisoalpha and hexahydroisoalpha acids |
US5296637A (en) * | 1992-12-31 | 1994-03-22 | Kalamazoo Holdings, Inc. | Production of odor-free tetrahydroisohumulates from alpha acids via their tetrahydrohumulates and subsequent isomerization |
WO1996031593A1 (en) * | 1995-04-06 | 1996-10-10 | John I. Haas, Inc. | Process for producing tetrahydroisoalpha acids |
-
1996
- 1996-05-20 DE DE1996120171 patent/DE19620171A1/en not_active Withdrawn
-
1997
- 1997-05-16 WO PCT/EP1997/002525 patent/WO1997044304A1/en not_active Application Discontinuation
- 1997-05-16 EP EP97923923A patent/EP0901455A1/en not_active Withdrawn
- 1997-05-16 AU AU29567/97A patent/AU2956797A/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419490A (en) * | 1978-08-17 | 1983-12-06 | Heyl & Co. Chemisch-Pharmazeutische Fabrik | Polymeric hydrogenation catalysts, the production thereof and their use to promote hydrogenation |
GB2217729A (en) * | 1987-03-25 | 1989-11-01 | Tadeval S A | Preparation of Squalane |
US5013571A (en) * | 1990-01-31 | 1991-05-07 | Pfizer Inc. | Methods for making tetrahydroisoalpha and hexahydroisoalpha acids |
US5296637A (en) * | 1992-12-31 | 1994-03-22 | Kalamazoo Holdings, Inc. | Production of odor-free tetrahydroisohumulates from alpha acids via their tetrahydrohumulates and subsequent isomerization |
WO1994015899A1 (en) * | 1992-12-31 | 1994-07-21 | Kalamazoo Holdings, Inc. | Production of odor-free tetrahydroisohumulates |
WO1996031593A1 (en) * | 1995-04-06 | 1996-10-10 | John I. Haas, Inc. | Process for producing tetrahydroisoalpha acids |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034762A1 (en) * | 1999-11-11 | 2001-05-17 | Miller Brewing Company | Method of hydrogenating iso-alpha acids in a buffered solution |
US6303824B1 (en) | 1999-11-11 | 2001-10-16 | Miller Brewing Company | Method of hydrogenating iso-α acids in a buffered solution |
AU777354B2 (en) * | 1999-11-11 | 2004-10-14 | Coors Brewing Company | Method of hydrogenating iso-alpha acids in a buffered solution |
US8766013B2 (en) | 2010-06-14 | 2014-07-01 | Katholieke Universiteit Leuven | Method for hydrogenation of iso-alpha-acids and tetrahydro-iso-alpha-acids to hexahydro-iso-alpha-acids |
CN106519086A (en) * | 2016-11-03 | 2017-03-22 | 哈尔滨工业大学 | Polyvinyl pyrrolidine imine high-molecular compound, and preparation method and applications thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2956797A (en) | 1997-12-09 |
EP0901455A1 (en) | 1999-03-17 |
DE19620171A1 (en) | 1997-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0071787B1 (en) | Ruthenium/carbon-hydrogenation catalysts, their preparation and their use in the selective hydrogenation of unsaturated carbonyl compounds | |
EP2393817A1 (en) | Method for producing 2,6-dioxabicyclo-(3.3.0)-octane-4,8-dione | |
CH401050A (en) | Getragener Katalysator | |
WO1997044304A1 (en) | Process for the catalytic hydrogenation of terpenoids | |
DE2832699A1 (en) | METHOD FOR PRODUCING SATURED ALIPHATIC, CYCLOALIPHATIC AND ARALIPHATIC ALDEHYDES | |
EP0024651B1 (en) | Process for the production of olefinically unsaturated carbonyl compounds and alcohols | |
EP0949233B1 (en) | Process for the preparation of sugar alcohols | |
DE2816460C3 (en) | Process for the preparation of asymmetric N-phenyl-N`-substituted p-phenylenediamines | |
DE3006867C2 (en) | Process for the production of higher saturated ketones | |
EP0323573B1 (en) | Process for the preparation of tertiary n,n-dimethyl amines | |
EP1108469B1 (en) | Hydrogenation catalyst activation | |
DE2923949A1 (en) | CATALYST FOR THE CATALYTIC HYDRATION OF 1,4-BUTINDIOLE TO 1,4-BUTANDIOLE | |
CH637936A5 (en) | METHOD FOR PRODUCING MORANOLINE AND N-METHYLMORANOLINE. | |
DE3325983C2 (en) | ||
DE2355737C2 (en) | Process for the preparation of 4-amino-diphenylamine | |
DE60206487T3 (en) | METHOD FOR THE DESALINATION OF A SUGAR SOLUTION AND ANION EXCHANGER | |
DE2343843A1 (en) | MEDICATIONS CONTAINING VICIANOSYLQUERCETINE AS THE ACTIVE SUBSTANCE, AND METHOD FOR THE MANUFACTURE OF THE ACTIVE SUBSTANCES | |
DE60303939T2 (en) | MANUFACTURE OF LIGHT-RELATED HOP PRODUCTS | |
EP1572354A1 (en) | Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst | |
DE1543769B2 (en) | 7-Methoxy-flavan derivatives, process for their preparation and pharmaceuticals containing them | |
EP0216180B1 (en) | Preparation of alkyltetrahydroanthrahydroquinones | |
EP1648916B1 (en) | Method for obtaining a natural mixture of conjugated equine estrogens | |
AT398975B (en) | METHOD FOR PRODUCING WATER-SOLUBLE PRIMYCIN AND ITS COMPONENTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
CH406175A (en) | Process for the preparation of a reduction product of oxidized starch | |
DE1941240A1 (en) | A hydrazide and its acid addition salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CN CZ JP RU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997923923 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97541509 Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997923923 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997923923 Country of ref document: EP |